MARYLAND

Medical (2014)
Decriminalized (2014)

Current Status

Maryland’s first legal protections for patients were established in 2003 with HB 702, the Darrell Putman Compassionate Use Act, which created an affirmative defense for patients possessing less than one ounce of marijuana that reduced convictions to a misdemeanor offense with a maximum $100 fine. In 2011, Maryland passed SB 308 to recognize specific medical conditions and remove the misdemeanor penalty, but not the $100 fine. In 2013, HB 180 expanded the affirmative defense to caregivers, while HB 1101 allowed “Academic Medical Centers” to conduct medical cannabis research studies and established the Natalie M. LaParade Medical Marijuana Commission to create regulations.


Medical Marijuana

To read the complete set of promulgated regulations, which became effective on September 14, 2015, go to the Division of State Documents website. The Natalie LaPrade Medical Commission regulations are in Subtitle 62.
Maryland Medical Cannabis Commission

In 2016, HB 104 was passed, allowing dentists, podiatrists, nurse midwives, and nurse practitioners, in addition to physicians, to issue written certifications to qualifying patients.

There are no explicit qualifying medical conditions in Maryland under HB 881/SB 923; instead, physicians must apply for permission to write recommendations for conditions they specify, although the Commission may add explicit qualifying conditions via rule making.

Cultivation

To read the complete set of promulgated regulations, which became effective on September 14, 2015, go to the Division of State Documents website. The Natalie LaPrade Medical Commission regulations are in Subtitle 62.
Medical Cannabis Grower License Application Requirements
Maryland Medical Cannabis Commission

Cannabis Grow Limit:
Home cultivation is not permitted.

Cannabis Possession Limit:
Qualified medical patients may possess a sufficient 30-day supply of marijuana for medical use.

Manufacturing/Processing

To read the complete set of promulgated regulations, which became effective on September 14, 2015, go to the Division of State Documents website. The Natalie LaPrade Medical Commission regulations are in Subtitle 62.
Processor License Application Requirements
Maryland Medical Cannabis Commission

**Applications for would-be entrepreneurs were closed on November 6, 2015. Currently, the state has not indicated when they will accept new applications.

Testing

To read the complete set of promulgated regulations, which became effective on September 14, 2015, go to the Division of State Documents website. The Natalie LaPrade Medical Commission regulations are in Subtitle 62.
Testing Facility Outline
Maryland Medical Cannabis Commission

**Applications for would-be entrepreneurs were closed on November 6, 2015. Currently, the state has not indicated when they will accept new applications.

Distribution/Dispensaries

To read the complete set of promulgated regulations, which became effective on September 14, 2015, go to the Division of State Documents website. The Natalie LaPrade Medical Commission regulations are in Subtitle 62.
Dispensary License Information
Maryland Medical Cannabis Commission

**Applications for would-be entrepreneurs were closed on November 6, 2015. Currently, the state has not indicated when they will accept new applications.

Maryland became the 21st state to legalize medical marijuana on April 14, 2014

Important Cannabis Laws

HB 702/SB 502 (2003) – The Darrell Putman Compassionate Use Act, which created an affirmative defense for patients possessing less than one ounce of marijuana that reduced convictions to a misdemeanor offense with a maximum $100 fine.

SB 308 (2011) : recognized specific medical conditions and remove the misdemeanor penalty, but not the $100 fine

HB 180 (2013) : expanded the affirmative defense to caregivers

HB 1101 (2013) : allowed “Academic Medical Centers” to conduct medical cannabis research studies and established the Natalie M. LaParade Medical Marijuana Commission to create regulations

HB 881/SB 923 (2014) : approved a comprehensive medical cannabis program that expanded and clarified legal protections for patients, caregivers, and physicians, and created a distribution system. Registered patients and their designated caregivers will be allowed to obtain and possess up to a 30-day supply of cannabis. Personal cultivation is prohibited. There are no explicit qualifying medical conditions in Maryland under HB 881/SB 923; instead, physicians must apply for permission to write recommendations for conditions they specify, although the Commission may add explicit qualifying conditions via rule making.

Revised by HB 490 (2015) : Renaming the Natalie M. LaPrade Medical Marijuana Commission to be the Natalie M. LaPrade Medical Cannabis Commission, the purpose of the Commission is to develop policies, procedures, guidelines, and regulations to implement programs to make medical cannabis available to qualifying patients in a safe and effective manner. Regulations went into effect on Sept. 14, 2015.

SB 517 (2015) : was passed, vetoed, and the veto overridden. It decriminalized the possession of marijuana paraphernalia.

HB 104 (2016) : allows dentists, podiatrists, nurse midwives, and nurse practitioners, in addition to physicians, to issue written certifications to qualifying patients.

Natalie LaPrade Medical Commission regulations are in Subtitle 62.